Latest Johnson & Johnson News & Updates

See the latest news and media coverage for J&J. We track all announcements, press releases, and industry mentions in real time, all in one place.

Johnson & Johnson (J&J)

Global healthcare company developing medicines and medical technologies

jnj.com

Headquarters: New Brunswick, United States
Company type: Public company
Number of employees: 130,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Johnson & Johnson (J&J)

In short: J&J reported Q3 sales growth and raised 2026 guidance despite a talc charge erasing 96% of profit.

Company announcements

October 13 J&J

J&J reports Q3 2026 sales growth and raises guidance

Reported sales reached $25.4 billion with operational growth of 5.9%. The company increased full-year estimated reported sales guidance to a midpoint of $101.2 billion.

July 27 J&J

J&J announces a proposed resolution of ovarian talc litigation

Conditioned on 95% participation, it involves a $5.5 billion commitment with payments starting in 2027.

July 14 J&J

J&J reports Q2 2026 results, raises 2026 outlook

Sales grew 6.6% to $25.3B, and adjusted EPS guidance increased by $0.13 to $11.68.

May 5 J&J

J&J announces JNJ-4804 Phase 2b data

JNJ-4804 shows superior clinical remission and endoscopic response in refractory UC and CD patients vs comparators. Supports Phase 3 advancement.

Media coverage

Today Yahoo Finance

Johnson & Johnson Just Took $7 Billion in Charges and Still Raised Its Outlook. Here's What That Tells Investors.

Johnson & Johnson's third-quarter 2026 earnings look terrible, until you dig into the story a little bit more.

October 22 MassDevice

J&J, Smith+Nephew plans for ortho megamerger reportedly fall through

J&J was looking to give its orthopedics unit a leg up by combining it with Smith+Nephew, but talks reportedly failed over who would be CEO.

October 13 Dagens industri

Johnson & Johnson raises forecast after better-than-expected results

The pharmaceutical giant reports an adjusted earnings per share of $2.59 for the third quarter of 2026.

October 13 ABCMoney

Johnson & Johnson talc charge wipes out 96% of quarterly profit

A Johnson & Johnson talc settlement charge erased 96% of Q3 profit even as the group raised 2026 guidance and shares fell sharply.

Never miss news about J&J

Track J&J and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

J&J competitors & trending companies

Browse news for competitors to J&J and other trending companies.